Literature DB >> 28946013

Manifestations of sickle cell disease on thoracic imaging.

Mindy X Wang1, Eric W Pepin2, Nupur Verma3, Tan-Lucien Mohammed4.   

Abstract

Sickle cell disease is an inherited hemolytic disease with systemic complications. These complications significantly impact the patients' quality of life. There are characteristic radiological findings that can aid in the diagnosis and management of common sequelae of sickle cell disease. In this review, we will discuss the thoracic imaging findings of common complications of sickle cell disease in an organ-based approach and provide imaging examples of them.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute chest syndrome; Autoinfarction; Computed tomography; Osteonecrosis; Pulmonary embolism; Sickle cell disease; Thoracic imaging

Mesh:

Year:  2017        PMID: 28946013     DOI: 10.1016/j.clinimag.2017.09.001

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  4 in total

Review 1.  Imaging review of sickle cell disease for the emergency radiologist.

Authors:  Shenise N Gilyard; Scott L Hamlin; Jamlik-Omari Johnson; Keith D Herr
Journal:  Emerg Radiol       Date:  2020-07-31

2.  Oral manifestations of sickle cell disease.

Authors:  M Chekroun; H Chérifi; B Fournier; F Gaultier; I-Y Sitbon; F Côme Ferré; B Gogly
Journal:  Br Dent J       Date:  2019-01-11       Impact factor: 1.626

3.  Antibiotics for treating acute chest syndrome in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Lucieni O Conterno; Jennifer M Knight-Madden
Journal:  Cochrane Database Syst Rev       Date:  2019-09-18

4.  Prevalence of enuresis and its impact in quality of life of patients with sickle cell disease.

Authors:  Alana de Medeiros Nelli; Flavia Cristina de Carvalho Mrad; Mateus de Andrade Alvaia; Heros Aureliano Antunes da Silva Maia; Carina Oliveira Silva Guimarães; Evanilda Souza de Santana Carvalho; Cristiano Mendes Gomes; José Murillo Bastos; Jose de Bessa
Journal:  Int Braz J Urol       Date:  2019 Sep-Oct       Impact factor: 3.050

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.